Reduced CSF CART in dementia with Lewy bodies.

Research output: Contribution to journalArticle

Abstract

Dementia with Lewy bodies (DLB) is the second most common form of neurodegenerative dementia after Alzheimer's disease (AD). The underlying neurobiological mechanism of DLB is not fully understood and no generally accepted biomarkers are yet available for the diagnosis of DLB. In a recent MRI study, DLB patients displayed hypothalamic atrophy whereas this region was not affected in AD patients. Cocaine and amphetamine regulated transcript (CART) is a neuropeptide expressed selectively in neurons in the hypothalamus. Here, we found that CSF CART levels were significantly reduced by 30% in DLB patients (n = 12) compared to controls (n = 12) as well as to AD patients (n = 14) using radioimmunoassay. Our preliminary results suggest that reduced CSF CART is a sign of hypothalamic dysfunction in DLB and that it may serve as a biomarker for this patient group.

Details

Authors
  • Kristofer Schultz
  • Sara Wiehager
  • Karin Nilsson
  • Jørgen E Nielsen
  • Suzanne G Lindquist
  • Lena E Hjermind
  • Birgitte B Andersen
  • Anders Wallin
  • Christer Nilsson
  • Åsa Petersén
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Neurosciences
Original languageEnglish
Pages (from-to)104-106
JournalNeuroscience Letters
Volume453
Issue number2
Publication statusPublished - 2009
Publication categoryResearch
Peer-reviewedYes

Bibliographic note

The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Department of Psychogeriatrics (013304000), Translational Neuroendocrinology (013210010)

Total downloads

No data available